Mannkind (MNKD) Assets Average (2011 - 2026)
Mannkind (MNKD) reported Assets Average of $768.3 million for Q1 2026, up 91.12% year-over-year from $402.0 million in Q1 2025, and up 19.41% quarter-over-quarter from $643.4 million in Q4 2025.
Mannkind (MNKD) Assets Average (2011 - 2026) Analysis & Trends
Mannkind (MNKD) has 16 years of Assets Average data on file, last reported at $768.3 million in Q1 2026.
- Assets Average for Q1 2026 came in at $768.3 million, up 91.12% year-over-year; the trailing twelve-month figure through Mar 2026 was $768.3 million (up 91.12% YoY), and the FY2025 annual result was $593.0 million, up 36.48% from the prior year.
- Assets Average grew to $768.3 million in Q1 2026 per MNKD's latest filing, from $643.4 million in the prior quarter.
- Over five years, Assets Average peaked at $768.3 million in Q1 2026 and troughed at $289.8 million in Q3 2022.
- A 5-year average of $412.6 million and a median of $402.0 million in 2025 frame the typical range for Assets Average.
- The sharpest annual moves came in 2025 and 2026: Assets Average fell 15.91% in 2025, then jumped 91.12% in 2026.
- A 5-year view of Assets Average shows it stood at $294.6 million in 2022, then soared by 35.04% to $397.8 million in 2023, then advanced by 7.86% to $429.0 million in 2024, then surged by 49.97% to $643.4 million in 2025, then grew by 19.41% to $768.3 million in 2026.
- Business Quant data shows MNKD's Assets Average at $768.3 million in Q1 2026, $643.4 million in Q4 2025, and $453.2 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 768.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 768.29 Mn |
| Dec 31, 2025 | 643.41 Mn |
| Sep 30, 2025 | 453.17 Mn |
| Jun 30, 2025 | 410.92 Mn |
| Mar 31, 2025 | 401.99 Mn |
| Dec 31, 2024 | 429.02 Mn |
| Sep 30, 2024 | 454.02 Mn |
| Jun 30, 2024 | 462.36 Mn |
| Mar 31, 2024 | 478.04 Mn |
| Dec 31, 2023 | 397.76 Mn |
| Sep 30, 2023 | 316.88 Mn |
| Jun 30, 2023 | 305.78 Mn |
| Mar 31, 2023 | 296.71 Mn |
| Dec 31, 2022 | 294.56 Mn |
| Sep 30, 2022 | 289.82 Mn |
| Jun 30, 2022 | 297.06 Mn |
| Mar 31, 2022 | 314.74 Mn |
| Dec 31, 2021 | 279.68 Mn |
| Sep 30, 2021 | 245.50 Mn |
| Jun 30, 2021 | 286.09 Mn |